2019年伊朗五种常见癌症:2019年伊朗五种常见癌症:发现癌症集群的二次分析
1Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Journal of primary care & community health
|July 31, 2023
概括
这项研究揭示了2019年伊朗最常见的癌症,重点是女性乳腺癌和男性前列腺癌. 研究结果绘制了伊朗各省份癌症患病率和地理分布的地图.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 癌症仍然是全球和伊朗的重大公共卫生问题.
- 了解常见癌症的流行率和地理分布对于有针对性的干预至关重要.
研究的目的:
- 利用2019年的数据,确定伊朗五种最常见的癌症的流行率.
- 分析这些流行癌症在不同伊朗省份的地理分布.
主要方法:
- 数据是从2019年全球疾病负担 (GBD) 研究中提取的.
- 根据性别和省份分析了癌症统计数据.
- 使用莫兰I测试来评估空间相关性,以确定癌症热点和冷点.
主要成果:
- 在女性中,最常见的癌症是乳腺 (312/100,000),甲状腺 (43/100,000),结肠和直肠 (43/100,000),白血病 (33/100,000) 和子宫 (29/100,000).
- 在男性中,最常见的癌症是前列腺癌 (219/100,000),结肠和直肠癌 (80/100,000),膀癌 (65/100,000),白血病 (40/100,000) 和丸癌 (33/100,000).
- 在各省确定了这些癌症的地理模式和重要集群.
结论:
- 乳腺,前列腺,结肠和直肠,膀,甲状腺,丸,子宫和白血病是伊朗最常见的癌症,不包括皮肤癌.
- 该研究为伊朗的癌症控制策略提供了必要的流行病学数据.
- 地理分析有助于理解癌症负担的区域差异.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
相关概念视频
01:21Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
01:20Comparing the Survival Analysis of Two or More Groups
224
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
224
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K